News Archives - QualityStocks

FridayJul 11, 2025 9:00 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Clears Regulatory Hurdle for 7.2 MW Hoadley Hill Solar Project in New York

The Hoadley Hill project has passed the CESIR process, a key step toward interconnection with the local grid. The 7.2 MW ground-mount solar array is expected to power the equivalent of 850 homes. The project is structured as a community solar initiative, enabling local residents to subscribe and receive utility bill credits. It will benefit from New York’s VDER compensation system, offering US$0.0971/kWh in projected year-one compensation. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout…

ThursdayJul 10, 2025 10:30 am

BluSky AI Inc. (BSAI): Building the Infrastructure Behind the Intelligence

BluSky AI is developing scalable, modular data centers purpose-built to support the explosive growth in AI and ML workloads Its “SkyMod” AI Factories use NVIDIA GPUs and attempt to use existing energy sources to deliver compute power where and when it’s needed With 90% of enterprises investing in AI but data center bottlenecks looming, BluSky AI provides the essential infrastructure to fuel the revolution As generative AI sweeps across industries, from healthcare to marketing to national defense, one major problem threatens to stall progress: infrastructure. The computer power required to support artificial intelligence is exponentially higher than traditional internet or…

ThursdayJul 10, 2025 9:45 am

Why Nevada’s Walker Lane Could Be the Next Big Thing in Gold Mining

Lahontan Gold's flagship Santa Fe Mine project sits in Nevada's prolific Walker Lane, a geological corridor that has produced some of North America's most significant gold discoveries The company's 1.95-million-ounce Au Eq resource base, combined with previous production of 359,202 ounces gold and 702,067 ounces silver, demonstrates proven mineralization in a mining-friendly jurisdiction With Basel III regulations now recognizing gold as a Tier 1 asset and institutional demand surging, well-positioned junior miners like Lahontan are attracting renewed investor attention The gold mining sector finds itself at a fascinating inflection point. While spot gold prices continue reaching new all-time highs, recently…

ThursdayJul 10, 2025 9:00 am

New ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) CEO Discusses Background, Outlines Direct Revenue Building Strategy, Offers Forecast for Gold Market

Vancouver-based ESGold recently announced a leadership transition, as new CEO Gordon Robb comes aboard and former CEO Paul Mastantuono moves into COO position The new CEO talked about how the company’s near-term cash flow strategy, moving right to production from processing historic tailings, funding future exploration, is a more attractive opportunity to a risk-off investor market ESGold expects to begin mill circuit production on a tailings cleanup project later this year at an abandoned mine in Quebec The company holds 265 mining claims on the historic Montauban mine site and expects the tailings cleanup to both improve the environment and…

WednesdayJul 09, 2025 9:45 am

ONAR Holding Corp. (ONAR): In Marketing’s AI Era, Strategy is Beating Speed

ONAR's network of technology-first agencies focuses on data-driven strategy and execution over flashy, reactive campaigns The company's proprietary AI platform Cortex drives results across integrated performance media, SEO, and industry-specialized marketing Recent industry studies show that sustainable growth in marketing is increasingly tied to strategic consistency and AI integration For years, speed was king in digital marketing. Agencies raced to deploy campaigns, iterate quickly, and exploit trends before they faded. But in 2025, this "move fast and break things" mindset is showing its limits. The rise of AI and the complexity of today’s customer journeys require more than just agility;…

WednesdayJul 09, 2025 9:00 am

Safe Pro Group Inc. (NASDAQ: SPAI) Is ‘One to Watch’

Unique, battle-tested and patented AI image analysis technology ready for commercialization in U.S. defense and public safety markets following more than two years of real-world usage in Ukraine. Well positioned to capitalize on U.S. military’s increased strategic focus on domestically produced drone and AI technologies through integration with currently deployed platforms such as the U.S. Army’s Tactical Assault Kit (“TAK”) ecosystem for military force protection. The patented SpotlightAI(TM) platform enables real-time detection of over 150 types of mines and UXO using AI and drone imagery and is now operating at scale, creating the world’s largest datasets of real-world landmines and…

TuesdayJul 08, 2025 9:45 am

Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap(R) Index, Signaling Growing Investor Recognition, Market Visibility

Safe Pro leverages patented AI and drone-based imagery analysis for threat detection and demining efforts. Membership in the index reflects the company’s growing market presence and performance in AI-powered security and defense solutions, boosting visibility among institutional investors and fund managers. The company’s flagship SpotlightAI(TM) platform has analyzed over 1.6 million real-world battlefield images from Ukraine, identifying more than 28,000 explosive threats. Safe Pro is targeting a share of the global $15 billion defense technology market through its U.S.-made and HUBZone-certified offerings. Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition…

TuesdayJul 08, 2025 9:00 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected to be immediately accretive to revenue and EBITDA. Cohen, serving the Sarasota-Bradenton area in Florida, specializes in treatments, including ketamine and TMS, for mood disorders, PTSD, and suicidal depression. HOPE Therapeutics is expanding toward a target of 30 clinics with a $100 million run rate by the end of 2025. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49%…

MondayJul 07, 2025 12:30 pm

New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Positioned to Supply Critical Global Silver Demand from Bolivia Assets

New Pacific Metals owns two of the largest undeveloped open-pit silver projects globally, both located in Bolivia. Its flagship Silver Sand project is projected to produce 12 million ounces of silver annually at low all-in sustaining costs. The Carangas project could add 6.6 million ounces of silver annually, with over 1 million ounces of gold potential at depth. New Pacific is working through Bolivia’s permitting process to unlock the upside potential of its high-quality, large-scale projects. Global silver demand, particularly for industrial and renewable energy applications, adds urgency to project development. New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a…

MondayJul 07, 2025 11:50 am

Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025

The FDA offered supportive feedback on Clene’s proposed statistical analysis plan during a recent Type C meeting. The neurofilament biomarker analysis results could support an accelerated approval submission for CNM-Au8 later in 2025. Clene has two additional FDA meetings scheduled in Q3 2025 to discuss ALS survival data and its MS program. Nearly 200 ALS patients are participating in the NIH-sponsored Expanded Access Program for CNM-Au8. The analysis aims to validate the neuroprotective effects shown in previous HEALEY Platform Trial results. Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving…

Site Search

Company Search

Category: News